Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is an GMP, ISO9001, ISO14001, OHS18001 authentication enterprise and so on. The trademark "REYOUNG" is famous trademark of China. Reyoung Pharma is No.1 of preparation exportion in 2018 in China.
This product is a semi synthetic preparation with the same antibacterial spectrum and mode of action as penicillin. Only this product is resistant to penicillinase and effective against penicillin resistant Staphylococcus, but its effect is weak. Because this product is stable in gastric acid, it can be taken orally. The product is widely distributed in the body, easy to enter into most tissues and body fluids, and can reach effective concentration in pleural effusion, pus, joint cavity and Purulent Osteomyelitis. It can be used in various infections caused by sensitive bacteria, such as pneumonia, sepsis, purulent meningitis and osteomyelitis, tonsillitis, peak fossa histitis and pyoderma.
It is mainly used for penicillin resistant Staphylococcus aureus infection, such as sepsis, pneumonia, mastitis, burn wound infection, etc.
This product is not damaged by penicillinase produced by Staphylococcus aureus, and it is effective to Staphylococcus aureus producing enzyme, but its antibacterial effect on non enzyme producing strains is not as good as penicillin G. This product is mainly used for penicillin G-resistant Staphylococcus aureus and Staphylococcus epidermidis, including viscera, skin and soft tissue infections, not applicable to central infection.Oxacillin Sodium API
The Packing Form:5kg/Alu-Tin, 2Tins/Carton